Schunemann, H., Ventresca, M., Crowther, M., Di Nisio, M., Briel, M., Zhou, Q., … Zulian, G. (2017). An Individual Participant Data Meta-Analysis of 13 Randomized Trials to Evaluate the Impact of Prophylactic Use of Heparin in Oncological Patients. In BLOOD (Vol. 130).

Schunemann, Holger, Matthew Ventresca, Mark Crowther, Marcello Di Nisio, Matthias Briel, Qi Zhou, Simon Noble, et al. “An Individual Participant Data Meta-Analysis of 13 Randomized Trials to Evaluate the Impact of Prophylactic Use of Heparin in Oncological Patients.” In BLOOD, Vol. 130, 2017.

Schunemann H, Ventresca M, Crowther M, Di Nisio M, Briel M, Zhou Q, et al. An Individual Participant Data Meta-Analysis of 13 Randomized Trials to Evaluate the Impact of Prophylactic Use of Heparin in Oncological Patients. In: BLOOD. 2017.

Schunemann, Holger, et al. “An Individual Participant Data Meta-Analysis of 13 Randomized Trials to Evaluate the Impact of Prophylactic Use of Heparin in Oncological Patients.” BLOOD, vol. 130, 2017.

Schunemann H, Ventresca M, Crowther M, Di Nisio M, Briel M, Zhou Q, Noble S, Macbeth F, Griffiths G, Garcia DA, Lyman GH, Iorio A, Mbuagbaw L, Neumann I, Van Es N, Brozek J, Guyatt G, Streiff MB, Brouwers M, Baldeh T, Marcucci M, Florez I, Solh Z, Ageno W, Bleker S, Bozas G, Buller H, Klerk C, Lebeau B, Lecumberri R, McBane RD, Sideras K, Maraveyas A, Pelzer U, Loprinzi C, Bossuyt P, Kahale L, Akl EA, Zulian G. An Individual Participant Data Meta-Analysis of 13 Randomized Trials to Evaluate the Impact of Prophylactic Use of Heparin in Oncological Patients. BLOOD. 2017.